Hydrogen-filled palladium nanosheets activated by light reportedly cleared Alzheimer’s amyloid plaques in mice and reduced oxidative stress markers in a preclinical study published in BMC Neuroscience. The approach combines a nanomaterial “weapon” with light activation and a mechanism aimed at shifting brain pathology toward a more favorable state. The work emphasizes a theranostic concept—treating pathology while using activation and readout cues to drive biological effects. While animal-only results limit direct clinical translation, such mechanistically targeted platforms remain a focal area for neurodegenerative therapeutic innovation. For the field, the key near-term question is whether the nanoparticle delivery strategy and safety profile can support movement beyond rodents.